Novocure Luxembourg’ s USD 400 million financing

Walder Wyss advised the funds managed by Pharmakon Advisors, an investor in non-dilutive debt for the life sciences industry and investment manager of the BioPharma credit funds. Banking and finance counsel Tervel Stoyanov (pictured left) led the team.

Novocure Luxembourg

Yoram Palti founded Novocure Luxembourg in 2000, a global oncology company engaged in the development, manufacture and commercialisation of tumour treatment fields (TTFields) for the treatment of solid tumours.